New pill could help shed pounds without needles

NCT ID NCT07243171

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral drug called ecnoglutide in 84 Chinese adults who are overweight or obese. The main goal is to check safety and how the body processes the drug, while also measuring weight changes. Participants take either the drug or a placebo daily for several weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ecnoglutide tablets

What this could lead to

If successful, this could lead to a new oral medication for weight management, offering a convenient alternative to injections.

What could go wrong

This is an early-phase trial with only 84 participants, so results may not apply broadly. Side effects and lack of efficacy are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WEIGHT MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • China-Japan Friendship Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

    Contact Phone: •••-•••-••••